Literature DB >> 925145

Demonstration of specific plasma protein binding sites for somatomedin.

R L Hintz, F Liu.   

Abstract

Native somatomedin (SM) has an apparent mol wt of at least 60,000 daltons, while all the purified SM peptides have mol wt 5-8,000 daltsons. We have studied the behavior of somatomedin in plasma during gel filtration at pH 8.1 and pH 2.8, and by the recombination of fractions. Using porcine bioassay for SM, displacement of 125I-insulin by SM, and binding of 125I-SM to plasma proteins, we can demonstrate that the disparity in apparent mol wt of SM is due to reversible binding to plasma proteins which are themselves biologically inactive. This binding site is specific for the SM peptides, saturable, and has high affinity and relatively low capacity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 925145     DOI: 10.1210/jcem-45-5-988

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  21 in total

Review 1.  Growth factors in the ovary.

Authors:  G Giordano; A Barreca; F Minuto
Journal:  J Endocrinol Invest       Date:  1992-10       Impact factor: 4.256

Review 2.  Somatomedins: chemical and functional characteristics of the different molecular forms.

Authors:  A Barreca; F Minuto
Journal:  J Endocrinol Invest       Date:  1989-04       Impact factor: 4.256

3.  Affinity-labeled plasma somatomedin-C/insulinlike growth factor I binding proteins. Evidence of growth hormone dependence and subunit structure.

Authors:  J R Wilkins; A J D'Ercole
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

4.  Differential regulation of insulin-like growth factor binding protein secretion from human decidual cells by IGF-I, insulin, and relaxin.

Authors:  K M Thraikill; D R Clemmons; W H Busby; S Handwerger
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

Review 5.  IGFBPs and neoplastic models. New concepts for roles of IGFBPs in regulation of cancer cell growth.

Authors:  Y Oh
Journal:  Endocrine       Date:  1997-08       Impact factor: 3.633

6.  Properties of endogenous somatostatin-like immunoreactivity and synthetic somatostatin in dog plasma.

Authors:  J M Conlon; C B Srikant; E Ipp; V Schusdziarra; W Vale; R H Unger
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

Review 7.  Acromegaly update--etiology, diagnosis and management.

Authors:  S Melmed; J A Fagin
Journal:  West J Med       Date:  1987-03

8.  Preferential association of the insulin-like growth factors I and II with metabolically inactive and active carrier-bound complexes in serum.

Authors:  H J Cornell; G Enberg; A C Herington
Journal:  Biochem J       Date:  1987-02-01       Impact factor: 3.857

9.  Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action.

Authors:  A J D'Ercole; A D Stiles; L E Underwood
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

10.  Hormonal and radiological effects of megavoltage radiotherapy in patients with growth hormone-secreting pituitary adenoma.

Authors:  E Ciccarelli; M R Valetto; E Vasario; T Avataneo; S Grottoli; F Camanni
Journal:  J Endocrinol Invest       Date:  1993-09       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.